There would be no comparative studies. Market ahs so little understanding of AVR. We are in the aortic stenosis space and jena valve is targeting aortic incompetence. Anyway 6months mortality of 19.3% is rather scary.
There would be no comparative studies. Market ahs so little...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.10 |
Change
-0.210(1.15%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $350.2K | 19.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.32 | 359 | 1 |
View Market Depth
| Last trade - 12.59pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |